These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1703822)

  • 41. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center.
    Dente CJ; Shaz BH; Nicholas JM; Harris RS; Wyrzykowski AD; Patel S; Shah A; Vercruysse GA; Feliciano DV; Rozycki GS; Salomone JP; Ingram WL
    J Trauma; 2009 Jun; 66(6):1616-24. PubMed ID: 19509623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Indications of blood components and outcome of transfusion practices in hemorrhage of multiple trauma].
    Audibert G
    Cah Anesthesiol; 1994; 42(3):391-4. PubMed ID: 7812868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy using blood components. Prerequisites, indications and clinical use].
    Glück D; Kubanek B; Ahnefeld FW
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogen reduction technologies: what are the concerns?
    AuBuchon JP
    Vox Sang; 2004 Jul; 87 Suppl 2():84-9. PubMed ID: 15209887
    [No Abstract]   [Full Text] [Related]  

  • 46. [Biophysical studies of blood products within the scope of the development of a blood component therapy program for surgical practice].
    Wilms K; Lange G; Vogel R; Wulf K
    Anaesthesiol Reanim; 1986; 11(6):319-30. PubMed ID: 3814306
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blood component therapy (author's transl)].
    Kretschmer V
    Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet collection during plasma exchange donation of cryoprecipitate.
    McLeod BC; Sassetti RJ; Cole ER; Scott JP
    Prog Clin Biol Res; 1990; 337():481-3. PubMed ID: 2112755
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparative analysis of different methods for routine blood component preparation.
    Heaton WA; Rebulla P; Pappalettera M; Dzik WH
    Transfus Med Rev; 1997 Apr; 11(2):116-29. PubMed ID: 9140171
    [No Abstract]   [Full Text] [Related]  

  • 50. Recent advances in the practice and technology of blood transfusion.
    Sandler SG
    Prim Care; 1980 Sep; 7(3):347-67. PubMed ID: 6777791
    [No Abstract]   [Full Text] [Related]  

  • 51. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogen reduction technology: methods, status of clinical trials, and future prospects.
    Corash L
    Curr Hematol Rep; 2003 Nov; 2(6):495-502. PubMed ID: 14561394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C.
    Suontaka AM; Silveira A; Söderström T; Blombäck M
    Vox Sang; 2005 Apr; 88(3):172-80. PubMed ID: 15787727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The changing of transfusion medicine. Use of blood components is more and more sophisticated. Sweden is self-sufficient concerning factor VIII].
    Högman C
    Lakartidningen; 1992 Apr; 89(17):1486-91. PubMed ID: 1573940
    [No Abstract]   [Full Text] [Related]  

  • 55. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
    Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
    Akush Ginekol (Sofiia); 1998; 37(4):46-9. PubMed ID: 10360055
    [No Abstract]   [Full Text] [Related]  

  • 56. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 57. [Perioperative management of coagulation].
    Innerhofer P
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S3-14. PubMed ID: 16953289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. World Apheresis Association.
    Rock G
    Transfus Apher Sci; 2010 Oct; 43(2):119. PubMed ID: 20888300
    [No Abstract]   [Full Text] [Related]  

  • 59. Simple transfer of cryoprecipitate.
    Roberts BJ; Salaman NE
    Anesthesiology; 1995 Dec; 83(6):1376. PubMed ID: 8533941
    [No Abstract]   [Full Text] [Related]  

  • 60. The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure.
    Alam A; Cserti-Gazdewich C; Pendergrast J
    Can J Anaesth; 2014 Mar; 61(3):284-6. PubMed ID: 24402838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.